Literature DB >> 11708859

A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics.

T C Falik-Zaccai1, Y Anikster, C E Rivera, M K Horne, L Schliamser, C Phornphutkul, D Attias, T Hyman, J G White, W A Gahl.   

Abstract

Gray platelet syndrome (GPS) is a disorder characterized by thrombocytopenia and large platelets that lack alpha granules and their contents. We describe two siblings with GPS who are members of a Moslem Bedouin genetic isolate. The children, an 8-year-old girl and a 5-year-old boy, had characteristic pale blue platelets lacking alpha granules on electron microscopy. Platelet aggregation studies were normal. The girl underwent a bone marrow aspiration and biopsy which showed mild myelofibrosis and extensive emperipolesis, i.e., the passage of other hematopoietic cells through megakaryocytes. Both children lacked high-molecular-weight multimers of von Willebrand factor (vWF) and had reduced activity and antigens of vWf. Platelet activation was approximately normal when ADP was employed as agonist, but significantly impaired using the thrombin receptor-activating peptide (TRAP). These findings are explained in light of the mechanism of action of each agonist. In addition, we propose that the emperipolesis was caused by increased P-selectin in megakaryocytes, and resulted in release of fibroblastic growth factors, explaining the myelofibrosis. The detailed description of these cases provides a basis for future differentiation of the various types of GPS, and for our current attempts to isolate the gene causing GPS in this genetic isolate. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708859     DOI: 10.1006/mgme.2001.3247

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

1.  The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome.

Authors:  D M Maynard; H F G Heijnen; W A Gahl; M Gunay-Aygun
Journal:  J Thromb Haemost       Date:  2010-05-27       Impact factor: 5.824

2.  Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.

Authors:  Meral Gunay-Aygun; Yifat Zivony-Elboum; Fatma Gumruk; Dan Geiger; Mualla Cetin; Morad Khayat; Robert Kleta; Nehama Kfir; Yair Anikster; Judith Chezar; Mauricio Arcos-Burgos; Adel Shalata; Horia Stanescu; Joseph Manaster; Mutlu Arat; Hailey Edwards; Andrew S Freiberg; P Suzanne Hart; Lauren C Riney; Katherine Patzel; Pranoot Tanpaiboon; Tom Markello; Marjan Huizing; Irina Maric; McDonald Horne; Beate E Kehrel; Kerstin Jurk; Nancy F Hansen; Praveen F Cherukuri; Marypat Jones; Pedro Cruz; Jim C Mullikin; Alan Nurden; James G White; William A Gahl; Tzippora Falik-Zaccai
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

Review 3.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

4.  Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice.

Authors:  Carsten Deppermann; Deya Cherpokova; Paquita Nurden; Jan-Niklas Schulz; Ina Thielmann; Peter Kraft; Timo Vögtle; Christoph Kleinschnitz; Sebastian Dütting; Georg Krohne; Sabine A Eming; Alan T Nurden; Beate Eckes; Guido Stoll; David Stegner; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

5.  Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice.

Authors:  Walter H A Kahr; Richard W Lo; Ling Li; Fred G Pluthero; Hilary Christensen; Ran Ni; Nima Vaezzadeh; Cynthia E Hawkins; Andrew S Weyrich; Jorge Di Paola; Carolina Landolt-Marticorena; Peter L Gross
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

6.  Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Authors:  Donna S Woulfe; Joanne Klimas Lilliendahl; Shelley August; Lubica Rauova; M Anna Kowalska; Magnus Abrink; Gunnar Pejler; James G White; Barbara P Schick
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

7.  Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.

Authors:  Christian A Di Buduo; Maria Adele Alberelli; Ana C Glembostky; Gianmarco Podda; Paola R Lev; Marco Cattaneo; Raffaele Landolfi; Paula G Heller; Alessandra Balduini; Erica De Candia
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

8.  Spontaneous 8bp Deletion in Nbeal2 Recapitulates the Gray Platelet Syndrome in Mice.

Authors:  Kärt Tomberg; Rami Khoriaty; Randal J Westrick; Heather E Fairfield; Laura G Reinholdt; Gary L Brodsky; Pavel Davizon-Castillo; David Ginsburg; Jorge Di Paola
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.